 | • レポートコード：GIR-107A14384 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗凝固治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗凝固治療薬の種類別市場規模（新規経口抗凝固治療薬（NOAC）、ワルファリン（VKA）、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗凝固治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：C. H. Boehringer Sohn (Germany)、Bristol-Myers Squibb (US)、Johnson & Johnson (US)、Pfizer (US)、Daiichi Sankyo (Japan)、Portola Pharmaceuticals (US)、Roche (Switzerland)、Abbott (US)、Siemens (Germany)、Alere (US)、CoaguSense (US) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：新規経口抗凝固治療薬（NOAC）、ワルファリン（VKA）、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・抗凝固治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗凝固治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗凝固治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗凝固治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗凝固治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anticoagulants Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anticoagulants Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Anticoagulants Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anticoagulants Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Novel Oral Anticoagulants (NOACs)
Warfarin (VKA)
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Anticoagulants Drug market are listed below:
C. H. Boehringer Sohn (Germany)
Bristol-Myers Squibb (US)
Johnson & Johnson (US)
Pfizer (US)
Daiichi Sankyo (Japan)
Portola Pharmaceuticals (US)
Roche (Switzerland)
Abbott (US)
Siemens (Germany)
Alere (US)
CoaguSense (US)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Anticoagulants Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anticoagulants Drug, with price, sales, revenue and global market share of Anticoagulants Drug from 2019 to 2021.
Chapter 3, the Anticoagulants Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticoagulants Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Anticoagulants Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Anticoagulants Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anticoagulants Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anticoagulants Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Novel Oral Anticoagulants (NOACs)
1.2.3 Warfarin (VKA)
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anticoagulants Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Anticoagulants Drug Market Size & Forecast
1.4.1 Global Anticoagulants Drug Sales in Value (2016-2026))
1.4.2 Global Anticoagulants Drug Sales in Volume (2016-2026)
1.4.3 Global Anticoagulants Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Anticoagulants Drug Production Capacity Analysis
1.5.1 Global Anticoagulants Drug Total Production Capacity (2016-2026)
1.5.2 Global Anticoagulants Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anticoagulants Drug Market Drivers
1.6.2 Anticoagulants Drug Market Restraints
1.6.3 Anticoagulants Drug Trends Analysis
2 Manufacturers Profiles
2.1 C. H. Boehringer Sohn (Germany)
2.1.1 C. H. Boehringer Sohn (Germany) Details
2.1.2 C. H. Boehringer Sohn (Germany) Major Business
2.1.3 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product and Services
2.1.4 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bristol-Myers Squibb (US)
2.2.1 Bristol-Myers Squibb (US) Details
2.2.2 Bristol-Myers Squibb (US) Major Business
2.2.3 Bristol-Myers Squibb (US) Anticoagulants Drug Product and Services
2.2.4 Bristol-Myers Squibb (US) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Johnson & Johnson (US)
2.3.1 Johnson & Johnson (US) Details
2.3.2 Johnson & Johnson (US) Major Business
2.3.3 Johnson & Johnson (US) Anticoagulants Drug Product and Services
2.3.4 Johnson & Johnson (US) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Pfizer (US)
2.4.1 Pfizer (US) Details
2.4.2 Pfizer (US) Major Business
2.4.3 Pfizer (US) Anticoagulants Drug Product and Services
2.4.4 Pfizer (US) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Daiichi Sankyo (Japan)
2.5.1 Daiichi Sankyo (Japan) Details
2.5.2 Daiichi Sankyo (Japan) Major Business
2.5.3 Daiichi Sankyo (Japan) Anticoagulants Drug Product and Services
2.5.4 Daiichi Sankyo (Japan) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Portola Pharmaceuticals (US)
2.6.1 Portola Pharmaceuticals (US) Details
2.6.2 Portola Pharmaceuticals (US) Major Business
2.6.3 Portola Pharmaceuticals (US) Anticoagulants Drug Product and Services
2.6.4 Portola Pharmaceuticals (US) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Roche (Switzerland)
2.7.1 Roche (Switzerland) Details
2.7.2 Roche (Switzerland) Major Business
2.7.3 Roche (Switzerland) Anticoagulants Drug Product and Services
2.7.4 Roche (Switzerland) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Abbott (US)
2.8.1 Abbott (US) Details
2.8.2 Abbott (US) Major Business
2.8.3 Abbott (US) Anticoagulants Drug Product and Services
2.8.4 Abbott (US) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Siemens (Germany)
2.9.1 Siemens (Germany) Details
2.9.2 Siemens (Germany) Major Business
2.9.3 Siemens (Germany) Anticoagulants Drug Product and Services
2.9.4 Siemens (Germany) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Alere (US)
2.10.1 Alere (US) Details
2.10.2 Alere (US) Major Business
2.10.3 Alere (US) Anticoagulants Drug Product and Services
2.10.4 Alere (US) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 CoaguSense (US)
2.11.1 CoaguSense (US) Details
2.11.2 CoaguSense (US) Major Business
2.11.3 CoaguSense (US) Anticoagulants Drug Product and Services
2.11.4 CoaguSense (US) Anticoagulants Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Anticoagulants Drug Sales by Manufacturer
3.1 Global Anticoagulants Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anticoagulants Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anticoagulants Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Anticoagulants Drug Manufacturer Market Share
3.4.2 Top 6 Anticoagulants Drug Manufacturer Market Share
3.5 Global Anticoagulants Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anticoagulants Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anticoagulants Drug Market Size by Region
4.1.1 Global Anticoagulants Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Anticoagulants Drug Revenue by Region (2016-2026)
4.2 North America Anticoagulants Drug Revenue (2016-2026)
4.3 Europe Anticoagulants Drug Revenue (2016-2026)
4.4 Asia-Pacific Anticoagulants Drug Revenue (2016-2026)
4.5 South America Anticoagulants Drug Revenue (2016-2026)
4.6 Middle East and Africa Anticoagulants Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anticoagulants Drug Sales in Volume by Type (2016-2026)
5.2 Global Anticoagulants Drug Revenue by Type (2016-2026)
5.3 Global Anticoagulants Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anticoagulants Drug Sales in Volume by Application (2016-2026)
6.2 Global Anticoagulants Drug Revenue by Application (2016-2026)
6.3 Global Anticoagulants Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anticoagulants Drug Sales by Type (2016-2026)
7.2 North America Anticoagulants Drug Sales by Application (2016-2026)
7.3 North America Anticoagulants Drug Market Size by Country
7.3.1 North America Anticoagulants Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Anticoagulants Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anticoagulants Drug Sales by Type (2016-2026)
8.2 Europe Anticoagulants Drug Sales by Application (2016-2026)
8.3 Europe Anticoagulants Drug Market Size by Country
8.3.1 Europe Anticoagulants Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Anticoagulants Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anticoagulants Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Anticoagulants Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Anticoagulants Drug Market Size by Region
9.3.1 Asia-Pacific Anticoagulants Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anticoagulants Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anticoagulants Drug Sales by Type (2016-2026)
10.2 South America Anticoagulants Drug Sales by Application (2016-2026)
10.3 South America Anticoagulants Drug Market Size by Country
10.3.1 South America Anticoagulants Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Anticoagulants Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anticoagulants Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Anticoagulants Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Anticoagulants Drug Market Size by Country
11.3.1 Middle East & Africa Anticoagulants Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anticoagulants Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anticoagulants Drug Typical Distributors
12.3 Anticoagulants Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anticoagulants Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anticoagulants Drug Revenue by Application, (USD Million), 2021-2026
Table 3. C. H. Boehringer Sohn (Germany) Basic Information, Manufacturing Base and Competitors
Table 4. C. H. Boehringer Sohn (Germany) Major Business
Table 5. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product and Services
Table 6. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bristol-Myers Squibb (US) Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb (US) Major Business
Table 9. Bristol-Myers Squibb (US) Anticoagulants Drug Product and Services
Table 10. Bristol-Myers Squibb (US) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Johnson & Johnson (US) Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson (US) Major Business
Table 13. Johnson & Johnson (US) Anticoagulants Drug Product and Services
Table 14. Johnson & Johnson (US) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer (US) Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer (US) Major Business
Table 17. Pfizer (US) Anticoagulants Drug Product and Services
Table 18. Pfizer (US) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Daiichi Sankyo (Japan) Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo (Japan) Major Business
Table 21. Daiichi Sankyo (Japan) Anticoagulants Drug Product and Services
Table 22. Daiichi Sankyo (Japan) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Portola Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
Table 24. Portola Pharmaceuticals (US) Major Business
Table 25. Portola Pharmaceuticals (US) Anticoagulants Drug Product and Services
Table 26. Portola Pharmaceuticals (US) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Roche (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 28. Roche (Switzerland) Major Business
Table 29. Roche (Switzerland) Anticoagulants Drug Product and Services
Table 30. Roche (Switzerland) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Abbott (US) Basic Information, Manufacturing Base and Competitors
Table 32. Abbott (US) Major Business
Table 33. Abbott (US) Anticoagulants Drug Product and Services
Table 34. Abbott (US) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Siemens (Germany) Basic Information, Manufacturing Base and Competitors
Table 36. Siemens (Germany) Major Business
Table 37. Siemens (Germany) Anticoagulants Drug Product and Services
Table 38. Siemens (Germany) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Alere (US) Basic Information, Manufacturing Base and Competitors
Table 40. Alere (US) Major Business
Table 41. Alere (US) Anticoagulants Drug Product and Services
Table 42. Alere (US) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. CoaguSense (US) Basic Information, Manufacturing Base and Competitors
Table 44. CoaguSense (US) Major Business
Table 45. CoaguSense (US) Anticoagulants Drug Product and Services
Table 46. CoaguSense (US) Anticoagulants Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Anticoagulants Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 48. Global Anticoagulants Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Anticoagulants Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Anticoagulants Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 51. Head Office and Anticoagulants Drug Production Site of Key Manufacturer
Table 52. Anticoagulants Drug New Entrant and Capacity Expansion Plans
Table 53. Anticoagulants Drug Mergers & Acquisitions in the Past Five Years
Table 54. Global Anticoagulants Drug Sales by Region (2016-2021e) & (K Pcs)
Table 55. Global Anticoagulants Drug Sales by Region (2021-2026) & (K Pcs)
Table 56. Global Anticoagulants Drug Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Anticoagulants Drug Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Anticoagulants Drug Sales by Type (2016-2021e) & (K Pcs)
Table 59. Global Anticoagulants Drug Sales by Type (2021-2026) & (K Pcs)
Table 60. Global Anticoagulants Drug Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Anticoagulants Drug Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Anticoagulants Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 63. Global Anticoagulants Drug Price by Type (2021-2026) & (USD/Pcs)
Table 64. Global Anticoagulants Drug Sales by Application (2016-2021e) & (K Pcs)
Table 65. Global Anticoagulants Drug Sales by Application (2021-2026) & (K Pcs)
Table 66. Global Anticoagulants Drug Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Anticoagulants Drug Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Anticoagulants Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 69. Global Anticoagulants Drug Price by Application (2021-2026) & (USD/Pcs)
Table 70. North America Anticoagulants Drug Sales by Country (2016-2021e) & (K Pcs)
Table 71. North America Anticoagulants Drug Sales by Country (2021-2026) & (K Pcs)
Table 72. North America Anticoagulants Drug Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Anticoagulants Drug Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Anticoagulants Drug Sales by Type (2016-2021e) & (K Pcs)
Table 75. North America Anticoagulants Drug Sales by Type (2021-2026) & (K Pcs)
Table 76. North America Anticoagulants Drug Sales by Application (2016-2021e) & (K Pcs)
Table 77. North America Anticoagulants Drug Sales by Application (2021-2026) & (K Pcs)
Table 78. Europe Anticoagulants Drug Sales by Country (2016-2021e) & (K Pcs)
Table 79. Europe Anticoagulants Drug Sales by Country (2021-2026) & (K Pcs)
Table 80. Europe Anticoagulants Drug Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Anticoagulants Drug Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Anticoagulants Drug Sales by Type (2016-2021e) & (K Pcs)
Table 83. Europe Anticoagulants Drug Sales by Type (2021-2026) & (K Pcs)
Table 84. Europe Anticoagulants Drug Sales by Application (2016-2021e) & (K Pcs)
Table 85. Europe Anticoagulants Drug Sales by Application (2021-2026) & (K Pcs)
Table 86. Asia-Pacific Anticoagulants Drug Sales by Region (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Anticoagulants Drug Sales by Region (2021-2026) & (K Pcs)
Table 88. Asia-Pacific Anticoagulants Drug Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Anticoagulants Drug Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Anticoagulants Drug Sales by Type (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Anticoagulants Drug Sales by Type (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Anticoagulants Drug Sales by Application (2016-2021e) & (K Pcs)
Table 93. Asia-Pacific Anticoagulants Drug Sales by Application (2021-2026) & (K Pcs)
Table 94. South America Anticoagulants Drug Sales by Country (2016-2021e) & (K Pcs)
Table 95. South America Anticoagulants Drug Sales by Country (2021-2026) & (K Pcs)
Table 96. South America Anticoagulants Drug Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Anticoagulants Drug Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Anticoagulants Drug Sales by Type (2016-2021e) & (K Pcs)
Table 99. South America Anticoagulants Drug Sales by Type (2021-2026) & (K Pcs)
Table 100. South America Anticoagulants Drug Sales by Application (2016-2021e) & (K Pcs)
Table 101. South America Anticoagulants Drug Sales by Application (2021-2026) & (K Pcs)
Table 102. Middle East & Africa Anticoagulants Drug Sales by Country (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Anticoagulants Drug Sales by Country (2021-2026) & (K Pcs)
Table 104. Middle East & Africa Anticoagulants Drug Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Anticoagulants Drug Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Anticoagulants Drug Sales by Type (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Anticoagulants Drug Sales by Type (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Anticoagulants Drug Sales by Application (2016-2021e) & (K Pcs)
Table 109. Middle East & Africa Anticoagulants Drug Sales by Application (2021-2026) & (K Pcs)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Anticoagulants Drug Typical Distributors
Table 113. Anticoagulants Drug Typical Customers
List of Figures
Figure 1. Anticoagulants Drug Picture
Figure 2. Global Anticoagulants Drug Sales Market Share by Type in 2020
Figure 3. Novel Oral Anticoagulants (NOACs)
Figure 4. Warfarin (VKA)
Figure 5. Others
Figure 6. Global Anticoagulants Drug Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Global Anticoagulants Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Anticoagulants Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Anticoagulants Drug Sales (2016-2026) & (K Pcs)
Figure 13. Global Anticoagulants Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 14. Global Anticoagulants Drug Production Capacity (2016-2026) & (K Pcs)
Figure 15. Global Anticoagulants Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Anticoagulants Drug Market Drivers
Figure 17. Anticoagulants Drug Market Restraints
Figure 18. Anticoagulants Drug Market Trends
Figure 19. Global Anticoagulants Drug Sales Market Share by Manufacturer in 2020
Figure 20. Global Anticoagulants Drug Revenue Market Share by Manufacturer in 2020
Figure 21. Anticoagulants Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Anticoagulants Drug Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Anticoagulants Drug Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Anticoagulants Drug Sales Market Share by Region (2016-2026)
Figure 25. Global Anticoagulants Drug Revenue Market Share by Region (2016-2026)
Figure 26. North America Anticoagulants Drug Revenue (2016-2026) & (USD Million)
Figure 27. Europe Anticoagulants Drug Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Anticoagulants Drug Revenue (2016-2026) & (USD Million)
Figure 29. South America Anticoagulants Drug Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Anticoagulants Drug Revenue (2016-2026) & (USD Million)
Figure 31. Global Anticoagulants Drug Sales Market Share by Type (2016-2026)
Figure 32. Global Anticoagulants Drug Revenue Market Share by Type (2016-2026)
Figure 33. Global Anticoagulants Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 34. Global Anticoagulants Drug Sales Market Share by Application (2016-2026)
Figure 35. Global Anticoagulants Drug Revenue Market Share by Application (2016-2026)
Figure 36. Global Anticoagulants Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 37. North America Anticoagulants Drug Sales Market Share by Type (2016-2026)
Figure 38. North America Anticoagulants Drug Sales Market Share by Application (2016-2026)
Figure 39. North America Anticoagulants Drug Sales Market Share by Country (2016-2026)
Figure 40. North America Anticoagulants Drug Revenue Market Share by Country (2016-2026)
Figure 41. United States Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Anticoagulants Drug Sales Market Share by Type (2016-2026)
Figure 45. Europe Anticoagulants Drug Sales Market Share by Application (2016-2026)
Figure 46. Europe Anticoagulants Drug Sales Market Share by Country (2016-2026)
Figure 47. Europe Anticoagulants Drug Revenue Market Share by Country (2016-2026)
Figure 48. Germany Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Anticoagulants Drug Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Anticoagulants Drug Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Anticoagulants Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Anticoagulants Drug Revenue Market Share by Region (2016-2026)
Figure 57. China Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Anticoagulants Drug Sales Market Share by Type (2016-2026)
Figure 64. South America Anticoagulants Drug Sales Market Share by Application (2016-2026)
Figure 65. South America Anticoagulants Drug Sales Market Share by Country (2016-2026)
Figure 66. South America Anticoagulants Drug Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Anticoagulants Drug Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Anticoagulants Drug Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Anticoagulants Drug Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Anticoagulants Drug Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Anticoagulants Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の新規経口抗凝固薬（NOAC）市場 2021：企業別、地域別、種類・用途別 The Novel Oral AntiCoagulants (NOAC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…- 注射可能抗凝固剤市場：世界及び中国市場分析・予測（～2024年） Injectable Anticoagulants Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Injectable Anticoagulants industry with a focus on the Chinese market. The report provides key statistics on the market status of the Injectable Anticoa…
- 世界の甲状腺機能低下症治療薬市場 2021：企業別、地域別、種類・用途別 The Hypothyroidism Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のゴセレリン薬市場 2021：企業別、地域別、種類・用途別 The Goserelin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の薬物乱用検査サービス市場 2021：企業別、地域別、種類・用途別 The Drug of Abuse Testing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …